Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare haematology Read more
AstraZeneca’s Savannah phase-II trial shows 49 per cent objective response in lung cancer patients Read more
Aleor Dermaceuticals receives US FDA final approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5% Read more